Regulatory Roundup: Ethics Group Calls on FTC to Investigate Drug Pricing

Article

ePT--the Electronic Newsletter of Pharmaceutical Technology

Ethics Group Calls on FTC to Investigate Drug Pricing

The Citizens for Responsibility and Ethics in Washington, a nonprofit organization dedicated to promoting ethics and accountability, sent a letter to the Federal Trade Commission (FTC) on July 6, 2010, asking for the commission to investigate drug companies “that offer significant discounts to doctors for providing patients with only that company’s vaccines.” The organization claims that Sanofi Pasteur and Merck “offer significant price discounts” if healthcare groups agree to buy their vaccines solely from one manufacturer. The organization states that this practice prevents doctors from using alternative vaccines, even when they may better meet patient needs.

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Leroy Hood, MD, PhD
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Related Content